Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06261827
NA

High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences

View on ClinicalTrials.gov

Summary

The primary aim of this single-center, prospective, randomized, controlled, study is to test the hypothesis that inhalation of NO 200 ppm prevents the development of nosocomial pneumonia in patients at risk after cardiac surgery under CPB. The study is interventional. Examination and treatment of patients is carried out in accordance with the approved standards of medical care for the relevant diseases. During the study, no experimental or unregistered (not approved for use) medical or diagnostic procedures in the territory of the Russian Federation will be carried out. The study includes patients admitted to the Cardiac Surgery Department of Cardiology Research Institute of Tomsk National Research Medical Center for elective surgery with CPB.

Official title: High-dose Inhaled NO Therapy for the pREvention of nosoCOmial Pneumonia After Cardiac Surgery Under caRDiopulmonary Bypass

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2024-02-20

Completion Date

2025-10-01

Last Updated

2026-06-24

Healthy Volunteers

No

Interventions

DRUG

Sham treatment

Oxygen-air mixture without NO after extubation after surgery for 5 days 2 times a day for 30 min

DRUG

200-ppm NO

NO will be supplemented at 200-ppm concentration after surgery for 5 days 2 times a day for 30 min

Locations (1)

Cardiology Research Institute Tomsk national Research Medical Center

Tomsk, Russia